• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

A Study of Irreducible Hernia: Clinical Presentation and Management

    Dr. Vaishak M Rai , Dr Mukteshwar N Deshmukh, Dr Pankaj Nandagawali, Dr. Khushbu O Gandhi

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 445-453

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: The anterior abdominal wall hernia is commonly encountered in surgical practice. When they present as complicated hernia, the complication, morbidity, and mortality are high even after standard protocol management. The present study was undertaken to assess the incidence of irreducible hernias presenting with complications, mode of clinical presentation and management of irreducible hernia.
Method: During the study period from May 2019 to Nov 2021, a total 53 clinically diagnosed case of irreducible hernia were studied which included groin hernia (66.6%) and anterior abdominal wall hernia [incisional hernia (22.6%), umbilical (1.88%), epigastric (1.88%), paraumbilical (3.9%)].
Results: The incidence of irreducible hernia was 3.2% (1650/53). Duration of existing hernia was common in 86.7% cases after 1-year. Maximum cases (74.8%) presented within 24-hours of onset of symptoms. The commonest symptoms were irreducible swelling (100%) and pain (85%). Maximum (52.8%) cases presented with bowel obstruction as complication. Cause of irreducibility was neck of hernial sac (56%) and adhesions (43.4%). Commonest operative procedure was release of constriction (56.6%) and adhesiolysis (43.3%). 56.6% cases developed post-operative complications and surgical site infections (SSI) was the commonest one (33.9%). No recurrence found during the study period. 3(5.6%) patients were expired, 2 patients died because of septicaemia secondary to anastomosis leak and 1 case ARDS. Conclusion: The present study clearly shows longer duration of existing hernia, existing co-morbidities, delay in operation in irreducible hernia is associated with definite complications and mortality. Hence, earlier hernia repair and not wasting crucial time when patient of irreducible hernia comes to hospital.
Keywords:
  • PDF (353 K)
  • XML
(2022). A Study of Irreducible Hernia: Clinical Presentation and Management. European Journal of Molecular & Clinical Medicine, 9(7), 445-453.
Dr. Vaishak M Rai , Dr Mukteshwar N Deshmukh, Dr Pankaj Nandagawali, Dr. Khushbu O Gandhi. "A Study of Irreducible Hernia: Clinical Presentation and Management". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 445-453.
(2022). 'A Study of Irreducible Hernia: Clinical Presentation and Management', European Journal of Molecular & Clinical Medicine, 9(7), pp. 445-453.
A Study of Irreducible Hernia: Clinical Presentation and Management. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 445-453.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 55
  • PDF Download: 174
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus